Discovery of Piperidol Derivatives for Combinational Treatment of Azole-Resistant Candidiasis
作者:Wanzhen Yang、Jie Tu、Changjin Ji、Zhuang Li、Guiyan Han、Na Liu、Jian Li、Chunquan Sheng
DOI:10.1021/acsinfecdis.0c00849
日期:2021.3.12
designed a series of antifungal benzocyclane derivatives based on the drug repurposing of haloperidol. Herein, further structural optimization and antifungal mechanism studies were performed, leading to the discovery of new piperidol derivative B2 with improved synergistic antifungal potency, selectivity, and water solubility. In particular, the combination of compound B2 and fluconazole showed potent in
需要有效的策略来应对由耐药真菌引起的侵袭性真菌感染。以前,我们根据氟哌啶醇的药物用途设计了一系列抗真菌苯并环烷衍生物。本文中,进行了进一步的结构优化和抗真菌机理研究,从而发现了具有改进的协同抗真菌效力,选择性和水溶性的新哌啶醇衍生物B2。特别地,化合物B2和氟康唑的组合显示出对耐唑的白色念珠菌的有效的体外和体内抗真菌活性。化合物B2通过调节与毒力相关的基因来抑制重要的毒力因子,并通过下调CYP51编码基因和外排泵基因来提高氟康唑的疗效。综上所述,哌啶醇衍生物B2代表了一种有前途的铅化合物,可用于抗唑类念珠菌病的联合治疗。